Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist...http://www.google.se/patents/US20050244463?utm_source=gb-gplus-sharePatent US20050244463 - Sustained release intraocular implants and methods for treating ocular vasculopathies
